Across TCGA pan-cancer cohorts, DSCAM Mutation is linked to patient survival in 11 of 34 cancer types, making it a survival-associated DSCAM data layer compared with 23 for mass-spec protein.
The strongest signal is observed in thymoma (THYM), where higher DSCAM Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated DSCAM expression acts as an unfavorable survival marker, although some lineages such as UCEC and SKCM show a favorable association.
THYM, KIRC, and THCA are the cancer types where DSCAM Mutation most reproducibly stratifies survival.
Mutation survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.